PD34-10 IMPACT OF DAROLUTAMIDE ON LOCAL SYMPTOMS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER

MLA

Charles J. Ryan, et al. “Pd34-10 Impact of Darolutamide on Local Symptoms in Patients with Nonmetastatic Castration-Resistant Prostate Cancer.” Journal of Urology, vol. 206, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0434d3b05a672405a6e847caaacea4c6&authtype=sso&custid=ns315887.

APA

Charles J. Ryan, Lawrence Karsh, Neal D. Shore, Frank Verholen, Zachary Klaassen, Marina Miskic, William J. Aronson, Arnulf Stenzl, Shankar Srinivasan, Ateesha F. Mohamed, & Christopher Pieczonka. (2021). Pd34-10 Impact of Darolutamide on Local Symptoms in Patients with Nonmetastatic Castration-Resistant Prostate Cancer. Journal of Urology, 206.

Chicago

Charles J. Ryan, Lawrence Karsh, Neal D. Shore, Frank Verholen, Zachary Klaassen, Marina Miskic, William J. Aronson, et al. 2021. “Pd34-10 Impact of Darolutamide on Local Symptoms in Patients with Nonmetastatic Castration-Resistant Prostate Cancer.” Journal of Urology 206 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0434d3b05a672405a6e847caaacea4c6&authtype=sso&custid=ns315887.